Avenue Therapeutics Inc

NASDAQ:ATXI  
1.28
-0.02 (-1.16%)
Products, Regulatory

Avenue Therapeutics Inc Says Co Received An Acknowledgement Letter From Office Of New Drugs Of Food And Drug Administration

Published: 09/21/2021 13:01 GMT
Avenue Therapeutics Inc (ATXI) - Avenue Therapeutics Inc - on September 17, Received an Acknowledgement Letter From Office of New Drugs of Food and Drug Administration.
Avenue Therapeutics Inc - Letter Stated That a Response Will Be Provided by October 28, 2021.
Avenue Therapeutics - Acknowledgement Letter Was Regarding Avenue's Fdrr Concerning Complete Response Letters Issued for NDA for Intravenous Tramadol.